FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019947765> ?p ?o ?g. }

• W2019947765 endingPage "3887" @default.
• W2019947765 startingPage "3879" @default.
• W2019947765 abstract "Tumor antigen (TA)-specific immunotherapy is an emerging approach for cancer treatment. Potent adjuvants are prerequisites to the immunotherapy for overcoming the low immunogenicity of TAs. We previously demonstrated that a bacterial flagellin, Vibrio vulnificus FlaB, has potent adjuvant activity in various vaccination models. In this study, we investigated whether the FlaB protein could be a potent adjuvant for a human papillomavirus 16 E6 and E7 (E6/E7) peptide-based anticancer immunotherapy. We used an E6/E7-expressing TC-1 carcinoma implantation animal model and tested TA-specific immunomodulation by FlaB. We co-administered the E6/E7 peptide either with or without FlaB into TC-1 tumor-bearing mice and then analyzed the antitumor activity of the peptide. FlaB significantly potentiated specific antitumor immune responses elicited by the peptide immunization, as evidenced by retarded in vivo tumor growth and significantly prolonged survival. We noticed that TC-1 cells do not express Toll-like receptor 5 (TLR5) on their surface and the TLR5 signaling pathway in TC-1 cells was not responsible for the antitumor effect of FlaB. FlaB potentiated the CTL activity and Ag-specific IFN-γ production of CD8+ T cells from the draining lymph node and spleen. In addition, this antitumor activity was abrogated following the in vivo depletion of CD8+ T cells and in TLR5 knockout (KO) or MyD88 KO mice. These results suggest that flagellin could enhance TA-specific CD8+ CTL immune responses through TLR5 stimulation in cancer immunotherapy." @default.
• W2019947765 created "2016-06-24" @default.
• W2019947765 creator A5005684865 @default.
• W2019947765 creator A5018553332 @default.
• W2019947765 creator A5020581414 @default.
• W2019947765 creator A5020931102 @default.
• W2019947765 creator A5021717111 @default.
• W2019947765 creator A5024813096 @default.
• W2019947765 creator A5028322924 @default.
• W2019947765 creator A5051593432 @default.
• W2019947765 creator A5068912027 @default.
• W2019947765 creator A5088446675 @default.
• W2019947765 date "2013-08-01" @default.
• W2019947765 modified "2023-10-17" @default.
• W2019947765 title "Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model" @default.
• W2019947765 cites W1488583473 @default.
• W2019947765 cites W1519633296 @default.
• W2019947765 cites W1522781268 @default.
• W2019947765 cites W1550542127 @default.
• W2019947765 cites W1655860314 @default.
• W2019947765 cites W1891981195 @default.
• W2019947765 cites W1966512662 @default.
• W2019947765 cites W1978146796 @default.
• W2019947765 cites W1981383297 @default.
• W2019947765 cites W1981831700 @default.
• W2019947765 cites W2009112167 @default.
• W2019947765 cites W2022234493 @default.
• W2019947765 cites W2037505794 @default.
• W2019947765 cites W2038475311 @default.
• W2019947765 cites W2046482090 @default.
• W2019947765 cites W2053736049 @default.
• W2019947765 cites W2057858743 @default.
• W2019947765 cites W2061269287 @default.
• W2019947765 cites W2075948284 @default.
• W2019947765 cites W2078743767 @default.
• W2019947765 cites W2081578705 @default.
• W2019947765 cites W2082960908 @default.
• W2019947765 cites W2084227342 @default.
• W2019947765 cites W2093265023 @default.
• W2019947765 cites W2094122762 @default.
• W2019947765 cites W2097229052 @default.
• W2019947765 cites W2105221079 @default.
• W2019947765 cites W2118962846 @default.
• W2019947765 cites W2120403825 @default.
• W2019947765 cites W2122741496 @default.
• W2019947765 cites W2125170732 @default.
• W2019947765 cites W2134631524 @default.
• W2019947765 cites W2136246490 @default.
• W2019947765 cites W2137695731 @default.
• W2019947765 cites W2142414417 @default.
• W2019947765 cites W2149903437 @default.
• W2019947765 cites W2152278126 @default.
• W2019947765 cites W2158653361 @default.
• W2019947765 cites W2160335594 @default.
• W2019947765 cites W2166024764 @default.
• W2019947765 doi "https://doi.org/10.1016/j.vaccine.2013.06.054" @default.
• W2019947765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23831323" @default.
• W2019947765 hasPublicationYear "2013" @default.
• W2019947765 type Work @default.
• W2019947765 sameAs 2019947765 @default.
• W2019947765 citedByCount "69" @default.
• W2019947765 countsByYear W20199477652014 @default.
• W2019947765 countsByYear W20199477652015 @default.
• W2019947765 countsByYear W20199477652016 @default.
• W2019947765 countsByYear W20199477652017 @default.
• W2019947765 countsByYear W20199477652018 @default.
• W2019947765 countsByYear W20199477652019 @default.
• W2019947765 countsByYear W20199477652020 @default.
• W2019947765 countsByYear W20199477652021 @default.
• W2019947765 countsByYear W20199477652022 @default.
• W2019947765 countsByYear W20199477652023 @default.
• W2019947765 crossrefType "journal-article" @default.
• W2019947765 hasAuthorship W2019947765A5005684865 @default.
• W2019947765 hasAuthorship W2019947765A5018553332 @default.
• W2019947765 hasAuthorship W2019947765A5020581414 @default.
• W2019947765 hasAuthorship W2019947765A5020931102 @default.
• W2019947765 hasAuthorship W2019947765A5021717111 @default.
• W2019947765 hasAuthorship W2019947765A5024813096 @default.
• W2019947765 hasAuthorship W2019947765A5028322924 @default.
• W2019947765 hasAuthorship W2019947765A5051593432 @default.
• W2019947765 hasAuthorship W2019947765A5068912027 @default.
• W2019947765 hasAuthorship W2019947765A5088446675 @default.
• W2019947765 hasConcept C126322002 @default.
• W2019947765 hasConcept C136449434 @default.
• W2019947765 hasConcept C147969180 @default.
• W2019947765 hasConcept C154317977 @default.
• W2019947765 hasConcept C167672396 @default.
• W2019947765 hasConcept C170493617 @default.
• W2019947765 hasConcept C202751555 @default.
• W2019947765 hasConcept C203014093 @default.
• W2019947765 hasConcept C2776090121 @default.
• W2019947765 hasConcept C2776709828 @default.
• W2019947765 hasConcept C2777338127 @default.
• W2019947765 hasConcept C2777701055 @default.
• W2019947765 hasConcept C2777863537 @default.
• W2019947765 hasConcept C2778378633 @default.
• W2019947765 hasConcept C2780674031 @default.
• W2019947765 hasConcept C2780868878 @default.

• next